Best content in Dr. Goodyear

Sort By: Most Recent | Popular Filter: All | Bookmarks | Topics Simple Middle

1More

L-theanine Administration Results in Neuroprot... [Phytother Res. 2013] - PubMed - NCBI - 0 views

shared by Nathan Goodyear on 15 Oct 13 - No Cached

35More

Elderly men over 65 years of age with late-onset hypogonadism benefit as much from test... - 0 views

www.ncbi.nlm.nih.gov/...PMC4392031 low T low Testosterone Testosterone men male hormone hormones late onset hypogonadism hypogonadism

shared by Nathan Goodyear on 21 May 15 - No Cached

The benefits of restoring serum testosterone in men with LOH were not significantly different between men older than 65 years of age and younger men. There were no indications that side effects were more severe in elderly men. The effects on prostate and urinary function and hematocrit were within safe margins.
...

Cancel
obesity, but also impaired general health, are the more common causes of low testosterone in aging men
...

Cancel
Severe LOH is associated with substantially higher risks of all-cause and cardiovascular mortality,
...

Cancel
...30 more annotations...
advanced age, obesity, a diagnosis of metabolic syndrome, and poor general health status were predictors of LOH
...

Cancel
Diabetes mellitus was correlated with hypogonadism in most studies
...

Cancel
coronary heart disease, hypertension, stroke, and peripheral arterial disease did not predict hypogonadism, they did correlate with the incidence of low testosterone
...

Cancel
LOH can be defined by the presence of at least three sexual symptoms associated with a total testosterone level of less than 11 nmol/L (3.2 ng/mL) and a free testosterone level of less than 220 pmol/L (64 pg/mL)
- Nathan Goodyear on 27 May 15
  
  the European Male Aging study defined low T as total < 320 ng/dl and free < 64 pg/ml.
  
  <div class="cArrow"> </div><div class="cContentInner">the European Male Aging study defined low T as total < 320 ng/dl and free < 64 pg/ml. </div>
  
  ...
  
  Cancel
...

Cancel
Mean weight decreased
...

Cancel
Waist circumference decreased
...

Cancel
Total cholesterol decreased
...

Cancel
Low-density lipoprotein decreased
...

Cancel
Triglycerides decreased
...

Cancel
High-density lipoprotein (HDL) increased
...

Cancel
ratio of total cholesterol to HDL improved
...

Cancel
Prostate volume increased
...

Cancel
PSA increased
...

Cancel
The benefits for men older than 65 years of age were compared with those of younger men, and the improvements in body weight, metabolic factors, psychological functioning, and sexual functioning were of the same magnitude in both age groups
...

Cancel
weight loss was progressive over the 6-year period, effects of testosterone on lipids and on psychological and sexual functioning reached a plateau after approximately 3 years and these effects were sustained
...

Cancel
Effects of testosterone on hematopoiesis, on the prostate, and on bladder function were not more severe in older men than in younger men
...

Cancel
observe a mild increase in prostate volume and serum PSA over time, which is a normal finding in aging men. Maybe somewhat surprising, postvoiding residue and the IPSS did not deteriorate with aging but showed a degree of improvement
...

Cancel
the severity of the metabolic syndrome is associated with the severity of lower urinary tract symptoms
...

Cancel
The symptoms of the metabolic syndrome improve upon testosterone treatment and testosterone may thus have a favorable effect on lower urinary tract symptoms
...

Cancel
it seems reasonable to conclude that the risks of testosterone administration to elderly men are not disproportionately higher in elderly men than in younger men.
...

Cancel
Despite evidence to the contrary, physicians still harbor a wrongful association between testosterone and the development of prostate pathology (prostate cancer and benign prostate hyperplasia)
...

Cancel
Not surprisingly, the incidence of prostate cancer was higher in older men; however, it was lower than expected in both groups
...

Cancel
These observations suggest that the incidence of prostate cancer in patients receiving testosterone therapy, both in the younger and in the older group, was not greater than in the general population not receiving testosterone treatment
...

Cancel
The historical fear that raising testosterone levels will result in more prostate cancer has been dispelled, particularly by the work of Abraham Morgentaler
...

Cancel
Higher serum testosterone levels fail to show an increased risk of prostate cancer, and supraphysiological testosterone does not increase prostate volume or PSA in healthy men
...

Cancel
This apparent paradox is explained by the "saturation model,"
...

Cancel
Recent studies indicate no increased risk of prostate cancer among men with serum testosterone in the therapeutic range
...

Cancel
In the present observational study, no cases of major adverse cardiovascular events occurred.
...

Cancel
the benefits of testosterone therapy are fully achieved only by long-term treatment
...

Cancel
To achieve maximal benefits, good patient adherence is a prerequisite
...

Cancel

Nathan Goodyear on 21 May 15

Study finds new difference in Testosterone benefits and/or side effects between men < 65 with low T and men > 65 with low T.

<div class="cArrow"> </div><div class="cContentInner">Study finds new difference in Testosterone benefits and/or side effects between men < 65 with low T and men > 65 with low T.</div>

...

Cancel